NO305536B1 - FremgangsmÕte for fremstilling av et komprimert oralt preparat - Google Patents

FremgangsmÕte for fremstilling av et komprimert oralt preparat

Info

Publication number
NO305536B1
NO305536B1 NO932053A NO932053A NO305536B1 NO 305536 B1 NO305536 B1 NO 305536B1 NO 932053 A NO932053 A NO 932053A NO 932053 A NO932053 A NO 932053A NO 305536 B1 NO305536 B1 NO 305536B1
Authority
NO
Norway
Prior art keywords
preparation
compressed oral
compressed
substance
oral preparation
Prior art date
Application number
NO932053A
Other languages
English (en)
Norwegian (no)
Other versions
NO932053D0 (no
NO932053L (no
Inventor
Bengt Lindstedt
Per Johan Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO932053D0 publication Critical patent/NO932053D0/no
Publication of NO932053L publication Critical patent/NO932053L/no
Publication of NO305536B1 publication Critical patent/NO305536B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO932053A 1990-12-07 1993-06-04 FremgangsmÕte for fremstilling av et komprimert oralt preparat NO305536B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations
PCT/SE1991/000814 WO1992010171A1 (fr) 1990-12-07 1991-12-03 Nouvelles formulations pharmaceutiques contenant une substance ionisable active pharmacologiquement et procede de preparation

Publications (3)

Publication Number Publication Date
NO932053D0 NO932053D0 (no) 1993-06-04
NO932053L NO932053L (no) 1993-07-20
NO305536B1 true NO305536B1 (no) 1999-06-21

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932053A NO305536B1 (no) 1990-12-07 1993-06-04 FremgangsmÕte for fremstilling av et komprimert oralt preparat

Country Status (17)

Country Link
US (2) US5707656A (fr)
EP (1) EP0560816B1 (fr)
JP (1) JP3276956B2 (fr)
AT (1) ATE444737T1 (fr)
AU (1) AU656346B2 (fr)
CA (1) CA2097176C (fr)
DE (1) DE69133623D1 (fr)
EE (1) EE03105B1 (fr)
FI (1) FI932553L (fr)
HU (1) HU218661B (fr)
IE (1) IE914136A1 (fr)
IS (1) IS1749B (fr)
NO (1) NO305536B1 (fr)
PT (1) PT99720B (fr)
SE (1) SE9003903D0 (fr)
WO (1) WO1992010171A1 (fr)
YU (1) YU186791A (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946145B1 (fr) * 1996-12-20 2008-09-03 McNeil-PPC, Inc. Medicaments antitussifs administres par des resines echangeuses d'ions
CA2379987A1 (fr) * 1999-07-29 2001-02-08 Roxane Laboratories, Inc. Preparation d'opioide a liberation continue
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
JP2005515966A (ja) * 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
EP1429728A1 (fr) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Preparations a liberation prolongee
EP1499295A4 (fr) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co Formulations de metoprolol a liberation prolongee
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
JPWO2007010900A1 (ja) * 2005-07-15 2009-01-29 Ｔｔｉ・エルビュー株式会社 貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
WO2007026671A1 (fr) * 2005-08-29 2007-03-08 Transcu Ltd. Dispositif de iontophorèse permettant de selectionner un medicament a administrer selon les informations provenant d'un capteur
KR20080056200A (ko) * 2005-09-16 2008-06-20 티티아이 엘뷰 가부시키가이샤 카테터형 이온토포레시스 장치
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
EP1944057A4 (fr) * 2005-09-30 2009-02-18 Tti Ellebeau Inc Appareil d'iontophorese capable de regler la dose et l'heure d'administration d'un inducteur de sommeil et d'un agent analeptique
AU2006299520A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
WO2008087803A1 (fr) * 2007-01-16 2008-07-24 Hokkaido University Préparation liposomale pour une iontophorèse incluant un composant anti-oxydant encapsulé
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
US20100069877A1 (en) * 2008-09-10 2010-03-18 Smith Gregory A Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
WO2010115015A1 (fr) * 2009-04-03 2010-10-07 Coating Place, Inc. Composition médicamenteuse pharmaceutique à libération modifiée

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (fr) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Comprimés contenant de la triméthothoprime et un sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
CA2002492A1 (fr) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Compose pharmaceutique contenant une resine echangeuse d'ions
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
JPH06503311A (ja) 1994-04-14
HU218661B (hu) 2000-10-28
JP3276956B2 (ja) 2002-04-22
YU186791A (sh) 1994-04-05
SE9003903D0 (sv) 1990-12-07
PT99720B (pt) 2002-04-29
CA2097176A1 (fr) 1992-06-08
HUT64213A (en) 1993-12-28
EP0560816B1 (fr) 2009-10-07
DE69133623D1 (de) 2009-11-19
PT99720A (pt) 1992-10-30
NO932053D0 (no) 1993-06-04
HU9301671D0 (en) 1993-09-28
FI932553A0 (fi) 1993-06-04
FI932553A7 (fi) 1993-06-04
AU656346B2 (en) 1995-02-02
IS1749B (is) 2000-07-11
IE914136A1 (en) 1992-06-17
WO1992010171A1 (fr) 1992-06-25
FI932553L (fi) 1993-06-04
IS3787A7 (is) 1992-06-08
EP0560816A1 (fr) 1993-09-22
EE03105B1 (et) 1998-08-17
AU8930591A (en) 1992-07-08
NO932053L (no) 1993-07-20
CA2097176C (fr) 2002-03-26
US5707656A (en) 1998-01-13
US5709882A (en) 1998-01-20
ATE444737T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
NO305536B1 (no) FremgangsmÕte for fremstilling av et komprimert oralt preparat
ATE95983T1 (de) Graduelle verabreichungsstrukturen fuer kaugummi.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
ATE147261T1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
ES2115231T3 (es) Emplasto con sustancias activas.
DE69011353D1 (de) Oral anzuwendende antifungale Arzneizubereitungen.
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
IT1217346B (it) Prodotto comprendente un composto organico del silicato combinato con una sostanza cosmeticamente attiva
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
ES2165640T3 (es) Acidos diaminocarboxilicos sustituidos.
ES2195220T3 (es) Acidos sulfonilaminocarboxilicos.
IT7823517A0 (it) Griglia saldata, in particolare per la protezione di cavita'sotterranee,complessi di cavita',come pure procedimento per la fabbricazione della griglia.
DE69034070D1 (de) Racemisches Huperzin A
ES2191987T3 (es) Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion.
NO994822D0 (no) Immunotolerant protrombinkomplekspreparat
IT8812585A0 (it) Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
SE8901003D0 (sv) Snabbloesliga preparat
ATE254851T1 (de) Iod-herstellungszusammensetzung
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
AU7458700A (en) Radioactive brachytherapy source and material and manufacturing method therefore
SE9902742D0 (sv) New pharmaceutical formultion
ES2040891T3 (es) Nuevo sistema plastificante hidrofilo y goma de mascar que contiene el mismo.
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003